CA960141A - PHARMACEUTICAL COMPOSITIONS CONTAINING .alpha. AND .beta. RECEPTOR BLOCKERS - Google Patents
PHARMACEUTICAL COMPOSITIONS CONTAINING .alpha. AND .beta. RECEPTOR BLOCKERSInfo
- Publication number
- CA960141A CA960141A CA122,764A CA122764A CA960141A CA 960141 A CA960141 A CA 960141A CA 122764 A CA122764 A CA 122764A CA 960141 A CA960141 A CA 960141A
- Authority
- CA
- Canada
- Prior art keywords
- beta
- alpha
- pharmaceutical compositions
- compositions containing
- receptor blockers
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH1461470 | 1970-10-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA960141A true CA960141A (en) | 1974-12-31 |
Family
ID=4402343
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA122,764A Expired CA960141A (en) | 1970-10-02 | 1971-09-14 | PHARMACEUTICAL COMPOSITIONS CONTAINING .alpha. AND .beta. RECEPTOR BLOCKERS |
Country Status (10)
| Country | Link |
|---|---|
| AU (1) | AU464325B2 (fr) |
| BE (1) | BE773408A (fr) |
| CA (1) | CA960141A (fr) |
| DE (1) | DE2147711A1 (fr) |
| ES (1) | ES395573A1 (fr) |
| FR (1) | FR2112248B1 (fr) |
| GB (1) | GB1369821A (fr) |
| IL (1) | IL37700A (fr) |
| NL (1) | NL7113533A (fr) |
| ZA (1) | ZA716148B (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ179623A (en) * | 1975-01-06 | 1978-03-06 | Ciba Geigy | Pharmaceutical preparation containing a beta-receptor blocking compound, a compound regulating thrombocyte function and optionally an alpha-receptor blocking compund |
-
1971
- 1971-09-13 IL IL37700A patent/IL37700A/xx unknown
- 1971-09-14 ZA ZA716148A patent/ZA716148B/xx unknown
- 1971-09-14 CA CA122,764A patent/CA960141A/en not_active Expired
- 1971-09-15 GB GB4298371A patent/GB1369821A/en not_active Expired
- 1971-09-24 DE DE19712147711 patent/DE2147711A1/de active Pending
- 1971-09-30 FR FR7135265A patent/FR2112248B1/fr not_active Expired
- 1971-09-30 ES ES395573A patent/ES395573A1/es not_active Expired
- 1971-09-30 AU AU34050/71A patent/AU464325B2/en not_active Expired
- 1971-10-01 NL NL7113533A patent/NL7113533A/xx unknown
- 1971-10-01 BE BE773408A patent/BE773408A/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FR2112248A1 (fr) | 1972-06-16 |
| GB1369821A (en) | 1974-10-09 |
| IL37700A (en) | 1975-05-22 |
| IL37700A0 (en) | 1971-11-29 |
| ZA716148B (en) | 1972-05-31 |
| AU3405071A (en) | 1973-04-05 |
| DE2147711A1 (de) | 1972-04-06 |
| BE773408A (fr) | 1972-04-04 |
| FR2112248B1 (fr) | 1975-04-18 |
| NL7113533A (fr) | 1972-04-05 |
| ES395573A1 (es) | 1974-12-01 |
| AU464325B2 (en) | 1975-08-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA955252A (en) | Pharmaceutical compositions | |
| IL36237A0 (en) | Substituted benzylimidazolidinones,their preparation and pharmaceutical compositions containing them | |
| AU450603B2 (en) | New pharmaceutical compositions | |
| IE34966L (en) | Pharmaceutical composition containing substitiuted¹biguanides | |
| HK13377A (en) | Pharmaceutical compositions | |
| AU3701671A (en) | Pharmaceutical formulations | |
| AU2682871A (en) | Pharmaceutical compositions | |
| CA969953A (en) | Pharmaceutical compositions | |
| AU3017971A (en) | Pharmaceutical composition | |
| CA960141A (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING .alpha. AND .beta. RECEPTOR BLOCKERS | |
| AU452135B2 (en) | Pharmaceutical compositions | |
| CA946083A (en) | Organopolysiloxane compositions | |
| IL38440A0 (en) | Substituted dioxypiperidines,their preparation and pharmaceutical compositions containing them | |
| IE36108B1 (en) | Pharmaceutical compositions | |
| CA976969A (en) | N-PYRIDYLALKYL-.beta.-ALKOXY-.beta.-TRIFLUOROMETHYLPHENALKYLAMINES | |
| CA959065A (en) | N-THIENYLALKYL-.beta.-ALKOXY-TRI-FLUOROMETHYL-PHENALKYLAMINES | |
| CA797800A (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING 1-METHYLISATIN .beta.-THIOSEMICARBAZONE | |
| CA853187A (en) | 17.alpha.-CHLORETHYNYL-17.beta.-HYDROXY-STEROIDS | |
| CA840974A (en) | Pharmaceutical composition | |
| CA1013254A (en) | Pharmaceutical composition | |
| CA840975A (en) | Pharmaceutical composition | |
| IE35495L (en) | Pharmaceutical compositions. | |
| CA845684A (en) | Pharmaceutical compositions | |
| AU456863B2 (en) | Pharmaceutical compositions | |
| AU458685B2 (en) | Pharmaceutical compositions |